FORTREA HOLDINGS INC. Income Tax Expense
FORTREA HOLDINGS INC. (FTRE) reported Income Tax Expense of $12.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-29
- FORTREA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $12.00M, a 185.71% increase year-over-year.
- FORTREA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $11.30M, a 24.16% decline year-over-year.
- FORTREA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-12-31 was -$3.10M.
- FORTREA HOLDINGS INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$12.80M.
- FORTREA HOLDINGS INC. income tax expense (benefit) for fiscal 2025 was $3.20M.
- FORTREA HOLDINGS INC. income tax expense (benefit) for fiscal 2024 was -$3.50M, a 391.67% decline from fiscal 2023.
- FORTREA HOLDINGS INC. income tax expense (benefit) for fiscal 2023 was $1.20M, a 97.08% decline from fiscal 2022.
- FORTREA HOLDINGS INC. income tax expense (benefit) for fiscal 2022 was $41.10M, a 7.03% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.00M 10-Q · filed 2026-07-29 | $23.30M 10-Q · filed 2026-07-29 | $20.20M derived: sum of 3 quarters · filed 2026-07-29 | $7.40M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $11.30M 10-Q · filed 2026-05-05 | $8.20M derived: sum of 2 quarters · filed 2026-05-05 | -$4.60M derived: sum of 3 quarters · filed 2026-05-05 | -$400.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.90M derived: sum of 2 quarters · filed 2026-02-26 | -$11.70M derived: sum of 3 quarters · filed 2026-07-29 | $3.20M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$12.80M 10-Q · filed 2025-11-05 | -$8.60M derived: sum of 2 quarters · filed 2026-07-29 | $6.30M 10-Q · filed 2025-11-05 | $5.30M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $4.20M 10-Q · filed 2026-07-29 | $19.10M 10-Q · filed 2026-07-29 | $18.10M derived: sum of 3 quarters · filed 2026-07-29 | $800.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $14.90M 10-Q · filed 2026-05-05 | $13.90M derived: sum of 2 quarters · filed 2026-05-05 | -$3.40M derived: sum of 3 quarters · filed 2026-05-05 | $7.30M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$18.30M derived: sum of 2 quarters · filed 2026-02-26 | -$7.60M derived: sum of 3 quarters · filed 2026-02-26 | -$3.50M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$17.30M 10-Q · filed 2025-11-05 | -$6.60M derived: sum of 2 quarters · filed 2025-11-05 | -$2.50M 10-Q · filed 2025-11-05 | -$8.60M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $10.70M 10-Q · filed 2025-08-06 | $14.80M 10-Q · filed 2025-08-06 | $8.70M derived: sum of 3 quarters · filed 2026-02-26 | $2.90M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $4.10M 10-Q · filed 2025-05-12 | -$2.00M derived: sum of 2 quarters · filed 2026-02-26 | -$7.80M derived: sum of 3 quarters · filed 2026-02-26 | $3.80M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$11.90M derived: sum of 2 quarters · filed 2026-02-26 | -$300.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.20M 10-K · filed 2026-02-26 | $4.50M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$5.80M 10-Q · filed 2024-11-08 | -$4.80M 10-Q · filed 2023-11-13 | $5.80M derived: sum of 2 quarters · filed 2024-11-08 | $7.30M 10-Q · filed 2024-11-08 | $9.50M 10-Q · filed 2023-11-13 | $12.60M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $11.60M 10-Q · filed 2024-08-12 | $10.60M 10-Q · filed 2023-08-14 | $13.10M 10-Q · filed 2024-08-12 | $14.30M 10-Q · filed 2023-08-14 | $18.40M derived: sum of 3 quarters · filed 2025-03-03 | $32.00M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-24 | $6.80M derived: sum of 2 quarters · filed 2025-03-03 | $20.40M derived: sum of 3 quarters · filed 2025-03-03 | $37.60M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $18.90M derived: sum of 2 quarters · filed 2025-03-03 | $36.10M derived: sum of 3 quarters · filed 2025-03-03 | $41.10M 10-K · filed 2025-03-03 | $44.10M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $13.60M 10-Q · filed 2023-11-13 | $30.80M derived: sum of 2 quarters · filed 2023-11-13 | $35.80M 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | $17.20M 10-Q · filed 2023-08-14 | $22.20M 10-Q · filed 2023-08-14 | ||||||
| 2021-12-31 | $38.40M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |